Artemis Medicare Services Latest Updates

Q3 FY26 Financial Performance Revenue and Profit Growth: For the quarter ended December 31, 2025, Artemis reported consolidated revenue of ₹272.35 crore, a 17.2% year-on-year (YoY) increase. Net profit (PAT) rose 7.9% YoY to ₹22.23 crore, supported by a sharp 40.8% sequential jump from the previous quarter. Operational Efficiency: Average Revenue Per Occupied Bed (ARPOB) grew by 10% YoY to ₹84,100. This was primarily driven by a surge in high-margin international patient revenue, which grew 34.9% and now contributes 34% of the total net revenue. Labor Code Impact: The company recognized an exceptional item of ₹3.07 crore during the quarter due to the impact of new Labour Codes, which influenced wage definitions and employee benefits. Aggressive Expansion & Fundraising ₹700 Crore Capital Raise: On February 2, 2026, the Board approved a fundraise of up to ₹700 crore through equity, convertible debentures, or a Qualified Institutions Placement (QIP). These funds are earmarked for long-term expansion and debt management. Capacity Triple-Up: The hospital group plans to scale its bed capacity from the current ~700 to 2,000 beds by 2028. The Gurugram flagship facility alone is set to expand to 1,000 beds, aided by a 15% increase in Floor Area Ratio (FAR) granted for its Platinum Green Building Certification. New Facilities: Construction of a 300+ bed super-specialty hospital in Raipur is advancing as planned, with operations expected to commence by April or May 2026. Stock & Market Context Price Volatility: Despite the robust operational results, the stock saw a sharp decline of over 8.5% on February 4, 2026, dropping to approximately ₹219. This follow-through selling has put the stock on a three-day losing streak, possibly due to market skepticism regarding near-term return ratios (ROE).